Open AccessIntra-atrial tumor thrombi secondary to hepatocellular carcinoma responding to chemotherapy
Author(s) -
Ajay Vallakati,
Preeti Chandra,
Robert Frankel,
Jacob Shani
Publication year - 2011
Publication title -
north american journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2250-1541
pISSN - 1947-2714
DOI - 10.4297/najms.2011.3435
Subject(s) - medicine , hepatocellular carcinoma , sorafenib , inferior vena cava , radiology , carcinoma , jaundice , surgery
Hepatocellular carcinoma accounts for 1-2.5% of all cancer in America with extension to inferior vena cava and right atrium in 1-4% of the cases. Patients with advanced hepatocellular carcinoma invading the right heart are considered poor candidates for surgery. In the past, such patients had dismal prognosis due to complications like pulmonary embolism and sudden death.